Close Menu

David Hamilton at Venture Beat covers the latest events at CIRM, the California Institute for Regenerative Medicine. While the $3 billion stem cell program has started disbursing funds to scientists, bad news continues to hound the endeavor. Most recently, Arlene Chiu, the interim chief scientific officer, resigned unexpectedly, Hamilton writes. Her departure follows on the heels of the resignation earlier this year of Zach Hall, CIRM's first president.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.